Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonisamide and Bupropion for Switching to Electronic Cigarettes
NCT04388319Phase 3Completed
- Sponsor
- Rose Research Center
- Start
- May 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zonisamide in nicotine dependence, sponsored by Rose Research Center. Started May 2020; status: completed.
02
Drugs
zonisamide
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT04388319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04388319.